Positive Wells Fargo conference updates on AUVELITY momentum and pipeline spark AXSM

 

Positive Wells Fargo conference updates on AUVELITY momentum and pipeline spark AXSM 7% gain

• AXSM rose ~7% intraday Sep 11 (from $211.12 close to ~$225+), rebounding from recent pullback.
• Management at Sep 9 Wells Fargo (and Sep 10 Cantor) conferences highlighted robust AUVELITY sales growth (51% YoY in Q2), sales force expansion to ~630 reps, positive early feedback on new Alzheimer's agitation launch, strong Medicare coverage.
• Broad market access, improving gross-to-net trends, and multiple Phase 3 catalysts expected 2026-2027 were emphasized, per transcripts released shortly before the move.
• Hints of potential share buybacks as capital allocation option noted as bullish given cash position and ~9% short interest.

https://finviz.com/stock?t=AXSM&p=d